Terms: = Breast cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Clinical Outcome
16 results:
1. Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor.
Song D; He H; Sinha I; Hases L; Yan F; Archer A; Haldosen LA; Zhao C; Williams C
Cancer Lett; 2021 May; 506():23-34. PubMed ID: 33652085
[TBL] [Abstract] [Full Text] [Related]
2. Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1.
He H; Song D; Sinha I; Hessling B; Li X; Haldosen LA; Zhao C
Oncogene; 2019 Jul; 38(28):5725-5738. PubMed ID: 31015574
[TBL] [Abstract] [Full Text] [Related]
3. Systematic identification of the key candidate genes in breast cancer stroma.
Wang Y; Xu H; Zhu B; Qiu Z; Lin Z
Cell Mol Biol Lett; 2018; 23():44. PubMed ID: 30237810
[TBL] [Abstract] [Full Text] [Related]
4. Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis.
Insua-Rodríguez J; Pein M; Hongu T; Meier J; Descot A; Lowy CM; De Braekeleer E; Sinn HP; Spaich S; Sütterlin M; Schneeweiss A; Oskarsson T
EMBO Mol Med; 2018 Oct; 10(10):. PubMed ID: 30190333
[TBL] [Abstract] [Full Text] [Related]
5. Metastasis-associated protein 1 is an upstream regulator of DNMT3a and stimulator of insulin-growth factor binding protein-3 in breast cancer.
Deivendran S; Marzook H; Santhoshkumar TR; Kumar R; Pillai MR
Sci Rep; 2017 Apr; 7():44225. PubMed ID: 28393842
[TBL] [Abstract] [Full Text] [Related]
6. Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in cancer Cells.
Gendelman R; Xing H; Mirzoeva OK; Sarde P; Curtis C; Feiler HS; McDonagh P; Gray JW; Khalil I; Korn WM
Cancer Res; 2017 Apr; 77(7):1575-1585. PubMed ID: 28087598
[TBL] [Abstract] [Full Text] [Related]
7. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; Shoji M; Murata T
Int J Oncol; 2016 Aug; 49(2):812-22. PubMed ID: 27221776
[TBL] [Abstract] [Full Text] [Related]
8. AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative breast cancer Progression.
Qiao Y; He H; Jonsson P; Sinha I; Zhao C; Dahlman-Wright K
J Biol Chem; 2016 Mar; 291(10):5068-79. PubMed ID: 26792858
[TBL] [Abstract] [Full Text] [Related]
9. Identification and evaluation of network modules for the prognosis of basal-like breast cancer.
Hallett RM; Cockburn JG; Li B; Dvorkin-Gheva A; Hassell JA; Bane A
Oncotarget; 2015 Jul; 6(19):17713-24. PubMed ID: 25991675
[TBL] [Abstract] [Full Text] [Related]
10. Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer.
Rudraraju B; Droog M; Abdel-Fatah TM; Zwart W; Giannoudis A; Malki MI; Moore D; Patel H; Shaw J; Ellis IO; Chan S; Brooke GN; Nevedomskaya E; Lo Nigro C; Carroll J; Coombes RC; Bevan C; Ali S; Palmieri C
Breast Cancer Res Treat; 2014 Sep; 147(2):295-309. PubMed ID: 25141981
[TBL] [Abstract] [Full Text] [Related]
11. Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.
Sun M; Isaacs GD; Hah N; Heldring N; Fogarty EA; Kraus WL
Mol Endocrinol; 2012 May; 26(5):736-47. PubMed ID: 22446103
[TBL] [Abstract] [Full Text] [Related]
12. Vinorelbine induces beta3-tubulin gene expression through an AP-1 Site.
Saussede-Aim J; Matera EL; Herveau S; Rouault JP; Ferlini C; Dumontet C
Anticancer Res; 2009 Aug; 29(8):3003-9. PubMed ID: 19661308
[TBL] [Abstract] [Full Text] [Related]
13. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.
Zhou Y; Yau C; Gray JW; Chew K; Dairkee SH; Moore DH; Eppenberger U; Eppenberger-Castori S; Benz CC
BMC Cancer; 2007 Apr; 7():59. PubMed ID: 17407600
[TBL] [Abstract] [Full Text] [Related]
14. Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.
Zhou Y; Eppenberger-Castori S; Marx C; Yau C; Scott GK; Eppenberger U; Benz CC
Int J Biochem Cell Biol; 2005 May; 37(5):1130-44. PubMed ID: 15743683
[TBL] [Abstract] [Full Text] [Related]
15. jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
[TBL] [Abstract] [Full Text] [Related]
16. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27.
Yang HY; Zhou BP; Hung MC; Lee MH
J Biol Chem; 2000 Aug; 275(32):24735-9. PubMed ID: 10859299
[TBL] [Abstract] [Full Text] [Related]
